AbbVie Inc. v. Sun Pharmaceutical Industries Limited
| AbbVie Inc. |
| Sun Pharmaceutical Industries Limited |
| 1:2023cv00684 |
| June 23, 2023 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 16, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 10
SO ORDERED Granting (D.I. 12 in 23-cv-374-RGA; D.I. 13 in 23-cv-607-RGA; D.I. 6 in 23-cv-750-RGA; D.I. 12 in 23-cv-448-RGA; D.I. 9 in 23-cv-684-RGA; D.I. 113 in 22-cv-1423-RGA-JLH; D.I. 13 in 23-cv-00470-RGA) Stipulation and Proposed Order Concerning Amended Complaint and Consolidation (see Order for further details). Signed by Judge Richard G. Andrews on 8/16/2023. Associated Cases: 1:22-cv-01423-RGA-JLH et al.(nms)
|
| Filing 9 STIPULATION and Proposed Order Concerning Amended Complaint and Consolidation, AbbVie Inc., AbbVie Ltd., Neurocrine Biosciences, Inc.. (Attachments: #1 Exhibit 1, #2 Exhibits A-G, #3 Supplemental ANDA form, #4 Supplemental ANDA form, #5 Supplemental ANDA form, #6 Amended Patent Report, #7 Exhibit 2)(Tigan, Jeremy) Modified on 8/10/2023 (nms). |
| Pro Hac Vice Attorneys Mitchell R. Williams, Jennell C. Bilek, Samuel T. Lockner, Caroline L. Marsili for Sun Pharmaceutical Industries Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Jennell C. Bilek, Samuel T. Lockner, Mitchell R. Williams, and Caroline L. Marsili - filed by Sun Pharmaceutical Industries Limited. (Wilson, Samantha) |
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Jennell C. Bilek, Samuel T. Lockner, Mitchell R. Williams, and Caroline L. Marsili, filed by Sun Pharmaceutical Industries Limited. Signed by Judge Richard G. Andrews on 7/24/2023. (nms)
|
| Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Sun Pharmaceutical Industries Limited. (Wilson, Samantha) |
| Filing 6 ANSWER to #1 Complaint and Separate Defenses, by Sun Pharmaceutical Industries Limited.(Gaza, Anne) Modified on 7/14/2023 (nms). |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc. (mkr) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,542,239 B2. (mkr) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 11, 2023. Date of Expiration of Patent: July 23, 2039. (mkr) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) |
| Filing 1 COMPLAINT for PATENT INFRINGEMENT filed against Sun Pharmaceutical Industries Limited (Filing fee $ 402, receipt number ADEDC-4164902.) - filed by AbbVie Inc. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (mkr) |
| No Summons Issued. (mkr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
